EP4651814A1 - Ajustements de vectorisation et de forme d'onde dynamique pour thérapie d'ablation - Google Patents

Ajustements de vectorisation et de forme d'onde dynamique pour thérapie d'ablation

Info

Publication number
EP4651814A1
EP4651814A1 EP23838236.0A EP23838236A EP4651814A1 EP 4651814 A1 EP4651814 A1 EP 4651814A1 EP 23838236 A EP23838236 A EP 23838236A EP 4651814 A1 EP4651814 A1 EP 4651814A1
Authority
EP
European Patent Office
Prior art keywords
waveform
electronic controller
ablation
treatment
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP23838236.0A
Other languages
German (de)
English (en)
Inventor
Daniel C. Sigg
Alexander J. Hill
Lars Mattison
Birce Onal
Khaldoun George TARAKJI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Inc filed Critical Medtronic Inc
Publication of EP4651814A1 publication Critical patent/EP4651814A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206—Generators therefor
    • A61B18/1233—Generators therefor with circuits for assuring patient safety
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/20—Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345—Vascular system
    • A61B2018/00351—Heart
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577—Ablation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00642—Sensing and controlling the application of energy with feedback, i.e. closed loop control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00666—Sensing and controlling the application of energy using a threshold value
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00666—Sensing and controlling the application of energy using a threshold value
    • A61B2018/00678—Sensing and controlling the application of energy using a threshold value upper
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00696—Controlled or regulated parameters
    • A61B2018/0072—Current
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00696—Controlled or regulated parameters
    • A61B2018/00726—Duty cycle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00696—Controlled or regulated parameters
    • A61B2018/00732—Frequency
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00696—Controlled or regulated parameters
    • A61B2018/0075—Phase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00696—Controlled or regulated parameters
    • A61B2018/00761—Duration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00696—Controlled or regulated parameters
    • A61B2018/00767—Voltage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00773—Sensed parameters
    • A61B2018/00839—Bioelectrical parameters, e.g. ECG, EEG
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00773—Sensed parameters
    • A61B2018/00875—Resistance or impedance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00898—Alarms or notifications created in response to an abnormal condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00988—Means for storing information, e.g. calibration constants, or for preventing excessive use, e.g. usage, service life counter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/16—Indifferent or passive electrodes for grounding
    • A61B2018/167—Passive electrodes capacitively coupled to the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/20—Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
    • A61B2034/2046—Tracking techniques
    • A61B2034/2048—Tracking techniques using an accelerometer or inertia sensor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/20—Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
    • A61B2034/2046—Tracking techniques
    • A61B2034/2051—Electromagnetic tracking systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02—Operational features
    • A61B2560/0223—Operational features of calibration, e.g. protocols for calibrating sensors
    • A61B2560/0238—Means for recording calibration data
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/04—Constructional details of apparatus
    • A61B2560/0487—Special user inputs or interfaces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/327—Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation

Definitions

  • This application relates generally to methods and systems associated with ablation catheters, ablation generators, and other medical devices and components used in various ablation procedures.
  • Ablation is a procedure used to treat cardiac arrhythmias. Some ablation procedures use heat or cold energy to create fibrosis or tiny scars in the heart to block irregular electrical signals to help the heart maintain a normal heart rhythm.
  • the delivery of some types of ablation therapy involves the use of a reliable, powerful, and precisely controlled source of electrical energy, e.g., in the form of a high-voltage pulse generator or a radio-frequency (RF) generator.
  • RF radio-frequency
  • CW sinusoids are delivered to the intended endocardial sites to perform reversible or irreversible electroporation in the case of pulsed field ablation (PFA), and thermally induced necrosis via RF using an ablationtherapy delivery device.
  • Reversible electroporation is typically used to reverse permeabilize cells to catalyze acceptance of genes or drugs, whereas irreversible electroporation is typically used to create permanent and lethal nanopores which can electrically isolate target areas of the myocardium and prevent arrhythmias, such as atrial fibrillation.
  • the use of RF energy creates lesions via thermal necrosis, which can isolate target areas of the myocardium.
  • an electronic controller connected to an ablation waveform generator operates to iteratively adjust a plurality of waveform parameters, in response to signals from medical monitoring equipment connected to a patient, to reduce, to a safe level, an adverse reaction of the patient to the applied waveform.
  • the iterative adjustment is performed based on calibration datasets representing lower-dimensional slices of a multidimensional space corresponding to the waveform-parameter space.
  • the adjustable waveform parameters include vectoring modality (e.g., monophasic or biphasic), a pulse amplitude, a pulse width, an interphase delay, an interpulse delay, and number of pulses in a pulse sequence.
  • vectoring modality e.g., monophasic or biphasic
  • a medical-treatment apparatus comprising an ablation waveform generator configured to apply electrical waveforms to a treatment element placeable in proximity to a treatment site of a patient and an electronic controller configured to control the ablation waveform generator and having an interface for receiving monitoring signals from medical monitoring equipment connected to the patient.
  • the electronic controller is further configured to: cause the ablation waveform generator to apply a test waveform to the treatment element; process the monitoring signals to evaluate an adverse reaction of the patient to the test waveform; and change a plurality of parameters of the test waveform to reduce the adverse reaction, the plurality of parameters being selected from the parameter group consisting of vectoring modality, a pulse amplitude, a pulse width, an interphase delay, and an inter-pulse delay.
  • Another example provides a medical-treatment method, comprising: providing an ablation waveform generator configured to apply electrical waveforms to a treatment element placeable in proximity to a treatment site of a patient; and configuring an electronic controller to: cause the ablation waveform generator to apply a test waveform to the treatment element; process monitoring signals received from medical monitoring equipment connected to the patient to evaluate an adverse reaction of the patient to the test waveform; and change a plurality of parameters of the test waveform to reduce the adverse reaction, the plurality of parameters being selected from the parameter group consisting of vectoring modality, a pulse amplitude, a pulse width, an interphase delay, and an interpulse delay.
  • FIGS. 1A-1B are block diagrams illustrating a medical system according to various examples.
  • FIGS. 2A-2B graphically illustrate electrical pulses that can be delivered to a treatment site using the medical system of FIGS. 1A-1B according to various examples.
  • FIG. 3 graphically illustrates an electrical waveform that can be delivered to a treatment site using the medical system of FIGS. 1A-1B according to various examples.
  • FIGS. 4-7 show graphs illustrating calibration datasets that can be used to configure the medical system of FIGS. 1A-1B according to various examples.
  • FIG. 8 is a flowchart illustrating a configuration method that can be used to operate the medical system of FIGS. 1A-1B according to various examples.
  • Neuromuscular stimulation is a clinical adverse event of PFA.
  • pulsed fields can excite certain tissues including nerves and smooth and striated (e.g., skeletal) muscles.
  • Clinical sequalae from stimulation of one or more skeletal muscles include patient discomfort and involuntary movement, which may disadvantageously lead to the use of deeper sedation.
  • Some pulsed fields can also directly stimulate pain fibers (e.g., A-delta and/or C- fibers) leading to the corresponding pain/discomfort. Stimulation of vagal structures can result in bradycardia and cough reflex.
  • the vagus nerve also known as the tenth cranial nerve, cranial nerve X, or CN X, is a cranial nerve that interfaces with the parasympathetic control of the heart, lungs, and digestive tract.
  • the vagus is the longest nerve of the autonomic nervous system in the human body and comprises both sensory and motor fibers.
  • stimulation of smooth muscle cells and/or autonomic nerve innervating vessels can lead to vasoconstriction and possibly vasospasms.
  • Electric fields generated using either current-controlled or voltage-controlled PFA generators can be vectored, e.g., to be unipolar or bipolar. Unipolar vectoring typically results in more neuromuscular stimulation than bipolar vectoring.
  • the ablation waveform can be selected, modified, and/or adjusted such that stimulation is reduced (e.g., minimized) while an intended therapeutic purpose is still achieved.
  • test waveform (not causing irreversible electroporation) is applied to determine whether an unwanted clinical effect occurs.
  • the test waveform is designed, configured, and/or selected based on the specific sensitive structure, such as a coronary artery, that is in the vicinity of the inserted energy-delivery structure (e.g., the corresponding catheter part).
  • the type(s) of measured response(s) depend(s) on the type of the sensitive structure, for example, heart rate for vagal stimulation, or ST segments for coronary stimulation.
  • a test waveform has some characteristics of the candidate treatment waveform, such as the number of pulses, pulse frequency, interpulse delays, pulse width, etc.
  • One or more different test waveforms are typically delivered to identify one or more candidate waveforms and then select a treatment waveform from the identified candidate waveforms.
  • ST segment refers to a portion of the electrocardiogram (often abbreviated as ECG or EKG) that represents the interval between ventricular depolarization and repolarization.
  • An ST segment abnormality e.g., elevation or depression
  • the QRS complex is a combination of the Q wave, R wave and S wave that represent ventricular depolarization and is usually the tallest, most- visible aspect of the ECG trace.
  • the ST segment directly follows the QRS complex. Importance of the ST segment is that it can provide important clues to physicians about potentially serious conditions, e.g., an impending heart attack.
  • the practitioner proceeds to: (i) change vectoring, e.g., from unipolar to bipolar, and/or (ii) adjust the waveform, e.g., to lower interphase and/or interpulse delays, and increase pulse frequencies to correspond to the nanosecond or low microsecond range.
  • change vectoring e.g., from unipolar to bipolar
  • adjust the waveform e.g., to lower interphase and/or interpulse delays, and increase pulse frequencies to correspond to the nanosecond or low microsecond range.
  • FIGS. 1A-1B are block diagrams illustrating a medical system 100 according to various examples. More specifically, FIG. 1A is a block diagram illustrating an overall view of the system 100. FIG. IB is a block diagram illustrating an electronic controller used in the system 100.
  • the system 100 includes a medical device 112 and the electronic controller 114 in communication with the medical device 112.
  • the medical device 112 is used to deliver energy (for example, PFA or electroporation energy) for treating or ablating an area of target tissue.
  • the medical device 112 is also used to deliver one or more test pulses or waveforms to evaluate a potential for an adverse reaction caused by the delivery of such energy.
  • the medical device 112 includes a catheter 102, a magnified view of a portion 101 of which is shown in FIG. 1A.
  • the catheter 102 has electrodes 118 for therapeutic interaction with the selected treatment site in or on the patient’s body.
  • the electrodes 118 deliver energy, for example, PFA energy, electroporation energy, test pulses and waveforms, and/or other transferred energy, to the treatment site.
  • the catheter 102 includes an elongated body 120 passable through the patient’s vasculature to enable placement of the electrodes 118 in proximity to the treatment site of a patient for diagnosis and/or treatment.
  • the elongated body 120 has a proximal portion 122 and a distal portion 124 and typically includes one or more lumens that provide mechanical, electrical, and/or fluid communication between the proximal portion 122 and the distal portion 124.
  • the elongated body 120 has a central or guidewire lumen 130 hosting a shaft 132 and a carrier arm 128.
  • the shaft 132 is longitudinally movable within and with respect to the guidewire lumen 130. In operation, longitudinal movement of the shaft 132 is used to cause the carrier arm 128 to transition between the first (e.g., substantially linear) configuration and a second (e.g., looped) configuration.
  • FIG. 1A shows the carrier arm 128 in the looped configuration.
  • the medical device 112 also includes a handle 140 connected to the proximal portion 122 of the elongated body 120.
  • the handle 140 includes circuitry and structures for properly operating and manipulating the catheter 102.
  • the handle 140 typically includes one or more connectors 104 for electrically connecting the circuitry to the electronic controller 114, e.g., to establish electrical paths between various pertinent parts of the medical device 112 and pertinent components or parts of the electronic controller 114.
  • the handle 140 also typically has one or more actuation or control features that enable the corresponding practitioner to control, deflect, steer, or otherwise manipulate the distal portion 124 via the proximal portion 122.
  • the system 100 also includes a navigation system 142 used for guiding a medical treatment procedure.
  • the medical device 112 is coupled to the electronic controller 114 through the navigation system 142.
  • both the medical device 112 and the navigation system 142 are directly coupled to the electronic controller 114.
  • the navigation system 142 is designed to help visualize the real-time position and orientation of the catheter 102 within the patient’s body to increase the accuracy of targeted ablation and reacquisition of pacing sites for re-ablation.
  • the navigation system 142 calculates the position and orientation of a catheter tip 108 using three magnetic sources 152, 154, 156 as references.
  • the navigation system 142 typically relies on static magnetic fields that are calibrated and can be computer controlled. Due to the nature of magnetic fields, the orientation of the carrier arm 128 can be calculated even when the tip 108 is stationary. By calculating the strength and orientation of the magnetic fields at a given location, the Cartesian coordinates (x, y, z) of the tip 108 are typically calculated together with the roll, pitch, and yaw angles of the carrier arm 128.
  • the electronic controller 114 includes components and circuits for the delivery of one or more energy modalities to the electrodes 118.
  • the electronic controller 114 includes an ablation waveform generator 144, control circuitry 146, and input/output (BO) devices 160.
  • the control circuitry 146 includes a processing circuit (e.g., a general-purpose processor) 148 and a memory 150.
  • the I/O devices 160 of the electronic controller 114 typically provide multiple I/O channels, e.g., including one or more channels 162 for communicating with the external monitoring devices, and at least one I/O channel 164 for operatively connecting the waveform generator 144 to the medical device 112 (also see FIG. 1A).
  • the electronic controller 114 is operable in a plurality of operating modes, which can be selected for specific medical procedures as needed or appropriate.
  • the memory 150 has buffers to temporarily store received data and nonvolatile data- storage devices to more permanently store data and program code.
  • the memory 150 provides pertinent data and program code to the processing circuit 148.
  • the program code when executed by the processing circuit 148 enables the electronic controller 114 to perform signal processing and generate various control and communication signals.
  • the processing circuit 148 performs rendering processing of input signals received from the external monitoring devices and outputs, through the VO devices 160, the corresponding viewable images, charts, and/or graphs for being viewed on an external display.
  • the medical monitoring devices include one or more devices from the following group of devices: a diaphragmatic or thoracic excursion assessment device; an accelerometer; an electromyography (EMG) machine; an ECG recorder; a vital signs monitor; an airway pressure monitor; and an expiratory carbon-dioxide monitor.
  • EMG electromyography
  • the VO devices 160 include at least one VO interface device for supporting a wireless data link.
  • the electronic controller 114 is also connected, via the VO devices 160, to an operator interface device 170.
  • the operator interface device 170 includes: a touch screen; buttons, knobs, and/or keys; light indicators (e.g., colored light emitting diodes, LEDs); a speaker; a switch; a joystick; and other control accessories connected and configured to enable the operator to properly operate the electronic controller 114 and the medical device 112.
  • the operator interface device 170 also typically enables the operator to see thereon at least some indicators generated by the electronic controller 114 in response to the signals received via the I/O devices 160 from the medical monitoring devices.
  • FIGS. 2A-2B graphically illustrate electrical pulses that can be delivered to the treatment site using the system 100 according to various examples. More specifically, FIG. 2A graphically illustrates a monophasic (unipolar) pulse 210. The monophasic pulse 210 has an amplitude Vo and a pulse width T p . Both the amplitude Vo and the pulse width T p are selectable and controllable via the waveform generator 144. FIG. 2B graphically illustrates a biphasic (bipolar) pulse 220. The biphasic pulse 220 includes a positive pulse 222 and a negative pulse 224.
  • Both the positive pulse 222 and the negative pulse 224 have the amplitude aVo and the pulse width T p , where a is the scaling factor, e.g., in the range between 0.1 and 10.
  • the time delay between the positive pulse 222 and the negative pulse 224 is di.
  • the parameter di is hereafter referred to as the interphase delay.
  • the parameters a and di of the biphasic pulse 220 are also selectable and controllable via the waveform generator 144.
  • FIG. 3 graphically illustrates an electrical waveform 300 that can be delivered to the treatment site using the system 100 according to various examples.
  • the electrical waveform 300 comprises a sequence of N biphasic pulses 220, which are labeled 220i, 2202, ..., 220N, respectively.
  • the time delay between two consecutive biphasic pulses 220 in the waveform 300 is d2.
  • the parameter d2 is hereafter referred to as the inter-pulse delay.
  • the total duration of the waveform 300 is T w . In various examples, the time T w is in the range between 0.1 ms and 10 ms.
  • the parameters N, d2, and T w of the waveform 300 are selectable and controllable via the waveform generator 144.
  • the pulse/waveform parameters described above in reference to FIGS. 2-3 represent an example multidimensional parameter space within which a specific set of parameter values is selected to deliver safe and effective ablation therapy to a specific treatment site of a specific patient.
  • selection is made based on calibration datasets and further using a system configuration method 800.
  • Nonlimiting examples of such calibration datasets are described in more detail below in reference to FIGS. 4-7.
  • the system configuration method 800 is described in more detail below in reference to FIG. 8.
  • FIGS. 4-7 show graphs illustrating calibration datasets that can be used to configure system 100 according to various examples. In a typical example, such calibration datasets are obtained using one or more clinical trials carried out using a relatively large set of different energy-delivery protocols.
  • the protocols are constructed using design-of-experiments (DOE) approaches.
  • DOE design-of-experiments
  • design of experiments refers to a branch of applied statistics that deals with planning, conducting, analyzing, and interpreting controlled tests to evaluate the factors that control the value of a parameter or a group of parameters, e.g., as applied to the above-mentioned parameter space of the system 100.
  • FIG. 4 is contour plot showing the amplitude of involuntary movement (AIM) as a function of the interphase delay di and the inter-pulse delay d2.
  • AIM involuntary movement
  • FIG. 5 is contour plot showing VAS values as a function of the average applied current and the inter-pulse delay d2.
  • VAS represents the Visual Analogue Scale, which is a pain rating scale often used in epidemiologic and clinical research to measure the intensity or frequency of various symptoms. For example, the amount of pain that a patient feels ranges across a continuum from no pain to an extreme amount of pain. From the patient’s perspective, the spectrum of pain appears continuous, i.e., does not typically take discrete jumps, as discrete pain-categorization scales might suggest. Unlike the latter, VAS values enable continuous sampling of the pain spectrum.
  • the set of calibration data shown in FIG. 5 was obtained by querying patients subjected to the sequence 300.
  • FIG. 6 is contour plot showing PRI values as a function of the amplitude a Vo and the interphase delay di.
  • PRI represents the Pain Rating Index obtained using a McGill Pain Questionnaire (MPQ).
  • the MPQ includes three major measures: the PRI, the number of words chosen to describe pain, and the present pain intensity.
  • the PRI is built by numerical grading of the words describing sensory, affective, and evaluative aspects of pain.
  • FIG. 7 is contour plot showing total pain-index (PI) values as a function of the amplitude aVo and the interphase delay di.
  • each of the total PI values is computed by taking a sum of the corresponding PRI value (also see FIG. 6) and the corresponding VAS value for the same vector value (aVo, di).
  • the set of calibration data shown in FIG. 7 was obtained by querying patients subjected to the sequence 300.
  • the calibration data used to configure the system 100 include a plurality of datasets representing slices of the above-mentioned multidimensional operating-parameter space of the system 100.
  • various dimensions of such multidimensional operating-parameter space include: the vectoring modality (e.g., monophasic or biphasic, FIGS. 2-3); the number of pulses in the pulse sequence 300 (e.g., N, FIG. 3); the pulse amplitude Vo; the scaling factor a; the pulse width T p ; the interphase delay di; and the inter-pulse delay d2 (also see FIGS. 2-3).
  • the calibration data are processed using suitable DOE analyses to construct a corresponding cost function for the optimization module of the electronic controller 114 to use in the method 800.
  • such DOE analyses include some or all of the following blocks:
  • Such graphs may include but are not limited to (a) response distributions, such as histograms, box plots, and the like; (b) responses versus time order scatter plots to check for possible time effects; (c) responses versus factor levels plots; (d) main effects mean plots; (e) normal or half-normal plots of the effects; (f) interaction plots; and (g) other suitable plots as applicable to system 100. At least some of the graphs may be conceptually analogous to the graphs illustrated in FIGS. 4-7.
  • (iii) Create a theoretical model of the responses.
  • the clinical trials are typically designed with a particular model in mind to enable sufficient sampling of the corresponding multidimensional parameter space.
  • the theoretical model is an analytical model, a numerical model, or a combination of analytical and numerical sub-models.
  • (iv) Refine the model using stepwise regression methods and/or parameter-value significance information and by fitting the calibration data with the model.
  • the above sequence of blocks is modified to be better suitable for the type of available calibration data. Not all types of experiments can be analyzed with one set procedure, and two or more different procedures may be used in the corresponding DOE analyses in such cases. In addition, medical-engineering judgment and overall expertise of persons of ordinary skill in the pertinent art can play a role in devising specific implementations of the above-outlined DOE-analysis sequence.
  • FIG. 8 is a flowchart illustrating the system configuration method 800 according to various examples.
  • the method 800 is implemented via the electronic controller 114 in a fully automatic mode, in which no additional input from the system’s human operator is needed after the method is initiated.
  • the method 800 has one or more checkpoints, wherein a human decision or prompt is solicited.
  • the remainder of the method 800 is still executed by the corresponding controller circuitry of the electronic controller 114 in an automated manner, e.g., by running a corresponding program code.
  • the method 800 includes applying a test waveform to the treatment site (in block 802).
  • the number n is in the range between 5 and 15.
  • the test waveform is selected based on adjusted parameters determined in block 812, e.g., as described below.
  • the method 800 also includes receiving (in block 804) one or more monitoring signals corresponding to a time period associated with the effects of the test waveform on the patient.
  • the monitoring signals are typically received by the electronic controller 114 through the I/O devices 160 as described above.
  • different sets of monitoring signals are received, with the specific signal types in such sets depending on the composition of the monitoring equipment linked up to the system 100 through the I/O devices 160.
  • the method 800 also includes the electronic controller 114 automatically evaluating (in decision block 806) the received monitoring signals for manifestations of an unacceptable adverse reaction to the test waveform from the patient.
  • such manifestation includes one or more of the following: (i) elevation or depression of the ST segment in the ECG trace; (ii) bradycardia, e.g., heart rate lower than 50 bpm; (iii) prolonged pauses in the heartbeat compared to the baseline heart rate; (iii) a coughing response or a coughing-like increase of airway pressure in an intubated patient;
  • the electronic controller 114 operates to automatically generate an alert (in block 808), e.g., intended for the attending physician.
  • the generated alert includes a corresponding alert banner or conspicuous message displayed on the screen of the operator interface device 170, a flashing LED light on the operator interface device 170, and/or a distinct sound emitted by the speaker of the operator interface device 170.
  • the attending physician or other qualified individual may decide to terminate or pause the method 800 and/or to take other warranted remedial action(s).
  • the electronic controller 114 When the quantifiers of various manifestations of the adverse reaction are all below the respective fixed threshold values (“No” in the decision block 806), the electronic controller 114 operates to skip the block 808.
  • the various fixed threshold values used to arrive at the warranted decision in the decision block 806 are the parameters of the optimization algorithm invoked by the method 800.
  • the method 800 also includes the electronic controller 114 computing (in decision block 810) a cost- function value based on the pertinent parameters of the test waveform used in the block 802 and further based on the monitoring signals received in the block 804.
  • the decision block 810 also includes comparing the computed cost-function value with a respective fixed threshold value, which is yet another parameter of the optimization algorithm. When the computed cost-function value is below the respective fixed threshold value (“Yes” in the decision block 810), the electronic controller 114 operates the system 100 to deliver (in block 814) the treatment waveform corresponding to the test waveform. Otherwise (“No” in the decision block 810), the processing of the method 800 is directed to block 812.
  • the method 800 also includes the electronic controller 114 changing (in the block 812) one or more parameters of the test waveform.
  • the one or more parameters being changed in the block 812 belong to the above-described multidimensional parameter space.
  • adjustments to the parameter values are determined using a cost-function optimization algorithm selected from the group consisting of: an algorithm based on evaluation of Hessians, a gradient-descent algorithm, a quasi-Newton method, and a particle- swarm-optimization algorithm. Additionally, other suitable costfunction optimization algorithms can be used, depending on the specific composition of the system 100 and the linked medical monitoring devices.
  • the adjusted parameter values are then used to configure an updated test waveform for use in the next instance of the block 802.
  • the processing loop including the blocks 802-812 typically causes several iterative adjustments to the waveform parameters until the “Yes” criteria are satisfied in the decision block 810, at which point the electronic controller 114 configures the system 100 to deliver the corresponding treatment waveform in the block 814.
  • an often-encountered change prompted by the above-described cost- function optimization algorithm in the first instance of the block 812 is the change of the vectoring modality from monophasic to biphasic.
  • finer tuning of the waveform occurs, typically via changes of the pulse width T p , interphase delay di, and inter-pulse delay d2, the interplay of which can be relatively complex.
  • the cost-function optimization algorithm handles such interplay in an incremental manner to move the cost-function value into the acceptable range, thereby causing the method 800 to exit the processing loop 802-812 and perform operations of the block 814.
  • a medical-treatment apparatus comprising: an ablation waveform generator configured to apply electrical waveforms to a treatment element placeable in proximity to a treatment site of a patient; and an electronic controller configured to control the ablation waveform generator and having an interface for receiving monitoring signals from medical monitoring equipment connected to the patient, the electronic controller being further configured to: cause the ablation waveform generator to apply a test waveform to the treatment element; process the monitoring signals to evaluate an adverse reaction of the patient to the test waveform; and change a plurality of parameters of the test waveform to reduce the adverse reaction, the plurality of parameters being selected from the parameter group consisting of vectoring modality, a pulse amplitude, a pulse width, an interphase delay, and an inter-pulse delay.
  • the electronic controller is further configured to cause the ablation waveform generator to apply a treatment waveform to the treatment element, the treatment waveform being generated based on parameter values determined based on the test waveform.
  • the monitoring equipment is selected from the group of devices consisting of a diaphragmatic or thoracic excursion assessment device, an accelerometer, an electromyography machine, an electrocardiogram recorder, a vital signs monitor, an airway pressure monitor, and a medical carbon-dioxide monitor.
  • the apparatus further comprises a catheter; and wherein the catheter includes the treatment element.
  • the electronic controller is configured to change the plurality of parameters based on calibration datasets representing lower-dimensional slices of a higher-dimensional parameter space corresponding to the plurality of parameters.
  • the electronic controller is configured to change the plurality of parameters based on a cost function constructed using the calibration datasets.
  • the electronic controller is further configured to perform iterative minimization of the cost function.
  • the apparatus further comprises an operator interface device; and wherein the electronic controller is further configured to cause the operator interface device to produce an alert signal when a quantifier of the adverse reaction exceeds a threshold value.
  • the apparatus further comprises a navigation system to guide the treatment element to the treatment site.
  • the electronic controller is further configured to change a number of biphasic pulses in the test waveform.
  • the apparatus is configured to perform a medical procedure selected from the group of procedures consisting of pulsed field ablation, RF ablation, reversible electroporation, and irreversible electroporation.
  • a medical-treatment method comprising: providing an ablation waveform generator configured to apply electrical waveforms to a treatment element placeable in proximity to a treatment site of a patient; and configuring an electronic controller to: cause the ablation waveform generator to apply a test waveform to the treatment element; process monitoring signals received from medical monitoring equipment connected to the patient to evaluate an adverse reaction of the patient to the test waveform; and change a plurality of parameters of the test waveform to reduce the adverse reaction, the plurality of parameters being selected from the parameter group consisting of vectoring modality, a pulse amplitude, a pulse width, an interphase delay, and an inter-pulse delay.
  • the electronic controller is further configured to cause the ablation waveform generator to apply a treatment waveform to the treatment element, the treatment waveform being generated based on parameter values determined based on the test waveform.
  • the monitoring equipment is selected from the group of devices consisting of a diaphragmatic or thoracic excursion assessment device, an accelerometer, an electromyography machine, an electrocardiogram recorder, a vital signs monitor, an airway pressure monitor, and a carbon-dioxide monitor.
  • the treatment element is a part of a catheter.
  • the electronic controller is configured to change the plurality of parameters based on calibration datasets representing lower-dimensional slices of a higher-dimensional parameter space corresponding to the plurality of parameters.
  • the electronic controller is configured to change the plurality of parameters based on a cost function constructed using the calibration datasets.
  • the electronic controller is further configured to perform iterative minimization of the cost function. [0061] In some examples of any of the above medical-treatment methods, the electronic controller is further configured to cause an operator interface device to produce an alert signal when a quantifier of the adverse reaction exceeds a threshold value.
  • the method further comprises performing a medical procedure selected from the group of procedures consisting of pulsed field ablation, RF ablation, reversible electroporation, and irreversible electroporation.
  • references herein to “one embodiment” or “an embodiment” means that a particular feature, structure, or characteristic described in connection with the embodiment can be included in at least one embodiment of the disclosure.
  • the appearances of the phrase “in one embodiment” in various places in the specification are not necessarily all referring to the same embodiment, nor are separate or alternative embodiments necessarily mutually exclusive of other embodiments. The same applies to the term ‘ ‘implementation . ’ ’
  • the conjunction “if’ may also or alternatively be construed to mean “when” or “upon” or “in response to determining” or “in response to detecting,” which construal may depend on the corresponding specific context.
  • the phrase “if it is determined” or “if [a stated condition] is detected” may be construed to mean “upon determining” or “in response to determining” or “upon detecting [the stated condition or event]” or “in response to detecting [the stated condition or event].”
  • the terms “couple,” “coupling,” “coupled,” “connect,” “connecting,” or “connected” refer to any manner known in the art or later developed in which energy is allowed to be transferred between two or more elements, and the interposition of one or more additional elements is contemplated, although not required.
  • the terms “directly coupled,” “directly connected,” etc. imply the absence of such additional elements.
  • attachment and “directly attached,” as applied to a description of a physical structure.
  • a relatively thin layer of adhesive or other suitable binder can be used to implement such “direct attachment” of the two corresponding components in such physical structure.
  • processors may be provided through the use of dedicated hardware as well as hardware capable of executing software in association with appropriate software.
  • the functions may be provided by a single dedicated processor, by a single shared processor, or by a plurality of individual processors, some of which may be shared.
  • processor or “controller” should not be construed to refer exclusively to hardware capable of executing software, and may implicitly include, without limitation, digital signal processor (DSP) hardware, network processor, application specific integrated circuit (ASIC), field programmable gate array (FPGA), read only memory (ROM) for storing software, random access memory (RAM), and nonvolatile storage. Other hardware, conventional and/or custom, may also be included.
  • DSP digital signal processor
  • ASIC application specific integrated circuit
  • FPGA field programmable gate array
  • ROM read only memory
  • RAM random access memory
  • nonvolatile storage nonvolatile storage.
  • Other hardware conventional and/or custom, may also be included.
  • any switches shown in the figures are conceptual only. Their function may be carried out through the operation of program logic, through dedicated logic, through the interaction of program control and dedicated logic, or even manually, the particular technique being selectable by the implementer as more specifically understood from the context.
  • circuitry may refer to one or more or all of the following: (a) hardware-only circuit implementations (such as implementations in only analog and/or digital circuitry); (b) combinations of hardware circuits and software, such as (as applicable): (i) a combination of analog and/or digital hardware circuit(s) with software/firmware and (ii) any portions of hardware processor(s) with software (including digital signal processor(s)), software, and memory(ies) that work together to cause an apparatus, such as a mobile phone or server, to perform various functions); and (c) hardware circuit(s) and or processor(s), such as a microprocessor(s) or a portion of a microprocessor(s), that requires software (e.g., firmware) for operation, but the software may not be present when it is not needed for operation.”
  • This definition of circuitry applies to all uses of this term in this application, including in any claims.
  • circuitry also covers an implementation of merely a hardware circuit or processor (or multiple processors) or portion of a hardware circuit or processor and its (or their) accompanying software and/or firmware.
  • circuitry also covers, for example and if applicable to the particular claim element, a baseband integrated circuit or processor integrated circuit for a mobile device or a similar integrated circuit in server, a cellular network device, or other computing or network device.
  • Example 1 A medical-treatment apparatus, comprising: an ablation waveform generator configured to apply electrical waveforms to a treatment element placeable in proximity to a treatment site of a patient; and an electronic controller configured to control the ablation waveform generator and having an interface for receiving monitoring signals from medical monitoring equipment connected to the patient, the electronic controller being further configured to: cause the ablation waveform generator to apply a test waveform to the treatment element; process the monitoring signals to evaluate an adverse reaction of the patient to the test waveform; and change a plurality of parameters of the test waveform to reduce the adverse reaction, the plurality of parameters being selected from the parameter group consisting of vectoring modality, a pulse amplitude, a pulse width, an interphase delay, and an inter-pulse delay.
  • an ablation waveform generator configured to apply electrical waveforms to a treatment element placeable in proximity to a treatment site of a patient
  • an electronic controller configured to control the ablation waveform generator and having an interface for receiving monitoring signals from medical monitoring equipment connected to the patient, the electronic controller being further configured to:
  • Example 2 The apparatus of Example 1, wherein the electronic controller is further configured to cause the ablation waveform generator to apply a treatment waveform to the treatment element, the treatment waveform being generated based on parameter values determined based on the test waveform.
  • Example 3 The apparatus of either Example 1 or Example 2, wherein the monitoring equipment is selected from the group of devices consisting of a diaphragmatic or thoracic excursion assessment device, an accelerometer, an electromyography machine, an electrocardiogram recorder, a vital signs monitor, an airway pressure monitor, and a blood pressure monitor.
  • the monitoring equipment is selected from the group of devices consisting of a diaphragmatic or thoracic excursion assessment device, an accelerometer, an electromyography machine, an electrocardiogram recorder, a vital signs monitor, an airway pressure monitor, and a blood pressure monitor.
  • Example 4 The apparatus of Example 1, further comprising a catheter; and wherein the catheter includes the treatment element.
  • Example 5 The apparatus of Example 1, wherein the electronic controller is configured to change the plurality of parameters based on calibration datasets representing lower-dimensional slices of a higher-dimensional parameter space corresponding to the plurality of parameters.
  • Example 6 The apparatus of Example 5, wherein the electronic controller is configured to change the plurality of parameters based on a cost function constructed using the calibration datasets.
  • Example 7 The apparatus of Example 6, wherein the electronic controller is further configured to perform iterative minimization of the cost function.
  • Example 8 The apparatus of any of Examples 1-7, further comprising an operator interface device; and wherein the electronic controller is further configured to cause the operator interface device to produce an alert signal when a quantifier of the adverse reaction exceeds a threshold value.
  • Example 9 The apparatus of any of Examples 1-8, further comprising a navigation system to guide the treatment element to the treatment site.
  • Example 10 The apparatus of any of Examples 1-9, wherein the electronic controller is further configured to change a number of pulses in the test waveform.
  • Example 11 The apparatus of any of Examples 1-10, wherein the apparatus is configured to perform a medical procedure selected from the group of procedures consisting of pulsed field ablation, radio-frequency ablation, reversible electroporation, and irreversible electroporation.
  • Example 12 A medical-treatment method, comprising: providing an ablation waveform generator configured to apply electrical waveforms to a treatment element placeable in proximity to a treatment site of a patient; and configuring an electronic controller to: cause the ablation waveform generator to apply a test waveform to the treatment element; process monitoring signals received from medical monitoring equipment connected to the patient to evaluate an adverse reaction of the patient to the test waveform; and change a plurality of parameters of the test waveform to reduce the adverse reaction, the plurality of parameters being selected from the parameter group consisting of vectoring modality, a number of pulses, a pulse amplitude, a pulse width, a pulse shape, an interphase delay, and an inter-pulse delay.
  • Example 13 The method of Example 12, wherein the electronic controller is further configured to cause the ablation waveform generator to apply a treatment waveform to the treatment element, the treatment waveform being generated based on parameter values determined based on the test waveform.
  • Example 14 The method of either Example 12 or Example 13, wherein the monitoring equipment is selected from the group of devices consisting of a diaphragmatic or thoracic excursion assessment device, an accelerometer, an electromyography machine, an electrocardiogram recorder, a vital signs monitor, an airway pressure monitor, and a carbon-dioxide monitor.
  • Example 15 The method of any of Examples 12-14, wherein the treatment element is a part of a catheter.
  • Example 16 The method of any of Examples 12-15, wherein the electronic controller is configured to change the plurality of parameters based on calibration datasets representing lower-dimensional slices of a higher-dimensional parameter space corresponding to the plurality of parameters.
  • Example 17 The method of Example 16, wherein the electronic controller is configured to change the plurality of parameters based on a cost function constructed using the calibration datasets.
  • Example 18 The method of Example 17, wherein the electronic controller is further configured to perform iterative minimization of the cost function.
  • Example 19 The method of any of Examples 12-18, wherein the electronic controller is further configured to cause an operator interface device to produce an alert signal when a quantifier of the adverse reaction exceeds a threshold value.
  • Example 20 The method of any of Examples 12-19, further comprising performing a medical procedure selected from the group of procedures consisting of pulsed field ablation, radio-frequency ablation, reversible electroporation, and irreversible electroporation.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Primary Health Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Plasma & Fusion (AREA)
  • Physics & Mathematics (AREA)
  • Robotics (AREA)
  • Urology & Nephrology (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Cardiology (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Electrotherapy Devices (AREA)

Abstract

L'invention concerne des méthodes et un appareil pour réaliser des actes d'ablation médicaux. Selon un exemple, un dispositif de commande électronique connecté à un générateur de forme d'onde d'ablation fonctionne de manière à ajuster itérativement une pluralité de paramètres de forme d'onde, en réponse à des signaux émanant d'un équipement de surveillance médical relié à un patient, pour réduire, à un niveau sûr, une réaction indésirable du patient à la forme d'onde appliquée. L'ajustement itératif est effectué sur la base d'ensembles de données d'étalonnage représentant des tranches de dimension inférieure d'un espace multidimensionnel correspondant à l'espace de paramètre de forme d'onde. Selon certains exemples, les paramètres de forme d'onde ajustables comprennent une modalité de vectorisation (par exemple monophasique ou biphasique), une amplitude d'impulsion, une largeur d'impulsion, un retard d'interphase, un retard interimpulsions et un nombre d'impulsions dans une séquence d'impulsions.
EP23838236.0A 2023-01-20 2023-12-21 Ajustements de vectorisation et de forme d'onde dynamique pour thérapie d'ablation Pending EP4651814A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363480775P 2023-01-20 2023-01-20
PCT/IB2023/063090 WO2024153994A1 (fr) 2023-01-20 2023-12-21 Ajustements de vectorisation et de forme d'onde dynamique pour thérapie d'ablation

Publications (1)

Publication Number Publication Date
EP4651814A1 true EP4651814A1 (fr) 2025-11-26

Family

ID=89542145

Family Applications (1)

Application Number Title Priority Date Filing Date
EP23838236.0A Pending EP4651814A1 (fr) 2023-01-20 2023-12-21 Ajustements de vectorisation et de forme d'onde dynamique pour thérapie d'ablation

Country Status (3)

Country Link
EP (1) EP4651814A1 (fr)
CN (1) CN120529873A (fr)
WO (1) WO2024153994A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11633121B2 (en) 2017-08-04 2023-04-25 Medtronic, Inc. Ablation check pulse routine and integration for electroporation
JP7461881B2 (ja) * 2017-12-26 2024-04-04 ガルヴァナイズ セラピューティクス，インコーポレイテッド 疾患状態および障害の治療のための方法、装置、およびシステム
WO2020190693A1 (fr) * 2019-03-15 2020-09-24 Boston Scientific Scimed, Inc. Générateur de forme d'onde et commande d'ablation sélective de cellules
US12193728B2 (en) * 2020-02-20 2025-01-14 The Board Of Trustees Of The Leland Stanford Junior University System and method for guiding direction to and treating targets for abnormal biological rhythms

Also Published As

Publication number Publication date
WO2024153994A1 (fr) 2024-07-25
CN120529873A (zh) 2025-08-22

Similar Documents

Publication Publication Date Title
US12558144B2 (en) Waveform generator and control for selective cell ablation
JP6200590B2 (ja) 電気生理学的マップを生成するためのシステムおよび方法
EP3790471A1 (fr) Système de traitement d'informations cardiaques
AU2020254707B2 (en) Method and system for monitoring tissue ablation through constrained impedance measurements
EP3706626A1 (fr) Sonde à électrode sophagienne et dispositif pour le traitement et/ou le diagnostic cardiologique(s)
US20250325322A1 (en) Pulsed-field ablation and mapping system
CN115349944A (zh) 脉冲消融系统
US20230310059A1 (en) Power supply device and power supply method
US8265752B2 (en) System and method for assessing atrial electrical stability
EP3841999A1 (fr) Traitement combiné par stimulation cardiaque et électroporation irréversible (ire)
US20240307121A1 (en) Predictive modeling and lesion zoneization and index/score from pfa application
US20240180616A1 (en) Annotation for electroporation ablation
US20230310871A1 (en) Pulsed electric field ablation for implantable medical devices
EP4651814A1 (fr) Ajustements de vectorisation et de forme d'onde dynamique pour thérapie d'ablation
WO2024211752A1 (fr) Optimisation d'onde de pouls pour minimiser la stimulation neuromusculaire pendant un traitement d'ablation par champ pulsé
CN117042839A (zh) 用于植入式脉冲发生器的引线定位
US20260083383A1 (en) Creating Electro-Anatomical Mappings of Cardiac Tissue Using Far Field Signals Received At Multiple Distances From An Electrode
US20260083381A1 (en) Creation of Electro-Anatomical Mappings of Cardiac Tissue At Different Depths
Stec et al. LEAD-mediated ventricular tachycardia and LEAD-mediated radiofrequency energy delivery-innovative LEAD2ER approach for hybrid ablation with transvenous lead extraction
Kumar et al. ADVANCING INSIGHTS AND INNOVATIVE TREATMENT STRATEGIES IN CARDIAC ARRHYTHMIAS: A COMPREHENSIVE REVIEW OF CURRENT DEVELOPMENTS AND THERAPEUTIC APPROACHES
CN121867924A (zh) 用于刺激或消融的医疗装置、系统和相关方法

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20250819

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)